Abstract
Purpose
The aim of this pilot study was to test whether mathematical parameters of the vascular morphology of choroidal neovascularization (CNV) can be used as biomarkers and to investigate how these parameters change during anti-vascular endothelial growth factor (VEGF) therapy.
Methods
Treatment-naive CNV in exudative age-related macular degeneration (AMD) was diagnosed in 28 patients. OCT-angiography (OCT-A) (Avanti/FA Optovue) performed before and after anti-VEGF therapy. The OCT-A data sets were exported to an external image processing program and vessel skeletonization was accomplished by means of edge detection. Based on this technique the total vessel length, the number of segments and the fractal dimension (FD) of the CNV were calculated before and after therapy. The results were compared with other clinical parameters such as VA and central retinal thickness (RT).
Results
The total vessel length of the CNV was significantly reduced by anti-VEGF-therapy (mean value 652 pixels vs. 397 pixels; p < 0.0001), as well as the number of individual vessel segments of the CNV (mean value 117 vs. 76; p < 0.0001). The FD of the CNV also decreased significant reduction during therapy (mean 1.23 vs. 1.16, p < 0.0001). The changes in these parameters during treatment corresponded with an increase in VA and a reduction in RT.
Conclusion
This pilot study demonstrates that the vascular pattern of CNV in AMD can be visualized and described using mathematical parameters of OCT-A. The changes during therapy correlate significantly with established “activity” parameters of CNV, so changes in these parameters (especially FD) may represent additional CNV “activity” biomarkers.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bressler NM. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol Chic Ill 1960. 2001;119:198–207.
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–44. https://doi.org/10.1056/NEJMoa062655.
Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina Phila Pa. 2010;30:1333–49. https://doi.org/10.1097/IAE.0b013e3181e7976b.
Matthé E, Sandner D. Early treatment of exudative age-related macular degeneration with ranibizumab (Lucentis®): the key to success. Ophthalmol Z Dtsch Ophthalmol Ges. 2011;108:237–43. https://doi.org/10.1007/s00347-010-2282-9.
Kuehlewein L, Bansal M, Lenis TL, Iafe NA, Sadda SR, Bonini Filho MA, et al. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol. 2015;160:739–.e2. https://doi.org/10.1016/j.ajo.2015.06.030
El Ameen A, Cohen SY, Semoun O, Miere A, Srour M, Quaranta-El Maft M, et al. Type 2 neovascularization secondary to age-related macular degeneration imaged by optical coherence tomography angiography. Retina Phila Pa. 2015;35:2212–8. https://doi.org/10.1097/IAE.0000000000000773.
Farecki M-L, Gutfleisch M, Faatz H, Rothaus K, Heimes B, Spital G, et al. Characteristics of type 1 and 2 CNV in exudative AMD in OCT-Angiography. Graefes Arch Clin Exp Ophthalmol. 2017:1–9. https://doi.org/10.1007/s00417-017-3588-y.
Coscas G, Lupidi M, Coscas F, Français C, Cagini C, Souied EH. Optical coherence tomography angiography during follow-up: qualitative and quantitative analysis of mixed type I and II choroidal neovascularization after vascular endothelial growth factor trap therapy. Ophthalmic Res. 2015;54:57–63. https://doi.org/10.1159/000433547.
Sulzbacher F, Pollreisz A, Kaider A, Kickinger S, Sacu S, Schmidt-Erfurth U. Identification and clinical role of choroidal neovascularization characteristics based on optical coherence tomography angiography. Acta Ophthalmol. 2017. https://doi.org/10.1111/aos.13364.
Spaide RF. Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization. Am J Ophthalmol. 2015. https://doi.org/10.1016/j.ajo.2015.04.012.
Costanzo E, Miere A, Querques G, Capuano V, Jung C, Souied EH. Type 1 choroidal neovascularization lesion size: indocyanine green angiography versus optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57:307–13. https://doi.org/10.1167/iovs.15-18830.
Faatz H, Rothaus K, Gunnemann F, Gutfleisch M, Heimes-Bussmann B, Lommatzsch A, et al. Changes in OCT Angiography of Type 2 CNV in Neovascular AMD during Anti-VEGF Treatment. Klin Monatsbl Augenheilkd. 2017;234:1125–31. https://doi.org/10.1055/s-0043-118346.
Rothaus K, Jiang X. Multi-scale midline extraction using creaseness. In: Pattern recognition and image analysis. Lecture Notes in Computer Science. Springer, Berlin, Heidelberg; 2005:502–11. https://doi.org/10.1007/11552499_56.
López AM, Lloret D, Serrat J, Villanueva JJ. Multilocal creaseness based on the level-set extrinsic curvature. Comput Vis Image Underst. 2000;77:111–44. https://doi.org/10.1006/cviu.1999.0812.
Souedan V, Souied EH, Caillaux V, Miere A, Ameen AE, Blanco-Garavito R. Sensitivity and specificity of optical coherence tomography angiography (OCT-A) for detection of choroidal neovascularization in real-life practice and varying retinal expertise level. Int Ophthalmol. 2017. https://doi.org/10.1007/s10792-017-0559-6
Palejwala NV, Jia Y, Gao SS, Liu L, Flaxel CJ, Hwang TS, et al. Detection of nonexudative choroidal neovascularization age-related macular degeneration with optical coherence tomography angiography: Retina. 2015;35:2204–11. https://doi.org/10.1097/IAE.0000000000000867.
Kuehlewein L, Sadda SR, Sarraf D. OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy. Eye Lond Engl. 2015;29:932–5. https://doi.org/10.1038/eye.2015.80.
Al-Sheikh M, Iafe NA, Phasukkijwatana N, Sadda SR, Sarraf D. Biomarkers of Neovascular activity in age-related macular degeneration using oct angiography. Retina Phila Pa.2017; https://doi.org/10.1097/IAE.0000000000001628.
Lumbroso B, Rispoli M, Savastano MC. Longitudinal optical coherence tomography-angiography study of type 2 naive choroidal neovascularization early response after treatment: Retina. 2015;35:2242–51. https://doi.org/10.1097/IAE.0000000000000879.
Lindner M, Fang PP, Steinberg JS, Domdei N, Pfau M, Krohne TU, et al. OCT angiography-based detection and quantification of the neovascular network in exudative AMD. Invest Ophthalmol Vis Sci. 2016;57:6342–8. https://doi.org/10.1167/iovs.16-19741.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Faatz, H., Farecki, ML., Rothaus, K. et al. Optical coherence tomography angiography of types 1 and 2 choroidal neovascularization in age-related macular degeneration during anti-VEGF therapy: evaluation of a new quantitative method. Eye 33, 1466–1471 (2019). https://doi.org/10.1038/s41433-019-0429-8
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41433-019-0429-8
This article is cited by
-
Developing quantitative analysis program of blood flow velocity according to vessel diameter for neovascular age-related macular degeneration using OCTA-VISTA
Scientific Reports (2024)
-
Volume-rendering three-dimensional image analysis of macular neovascularization in age-related macular degeneration
Eye (2024)
-
Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment
Scientific Reports (2023)
-
Imaging endpoints for clinical trials in MacTel type 2
Eye (2022)
-
Correlation of retinal alterations with vascular structure of macular neovascularisation in swept-source optical coherence tomography angiography in age-related macular degeneration
International Ophthalmology (2022)
